GLP-1 medications (like semaglutide and tirzepatide) were designed for metabolic disease, but they've become the headline in weight loss. The hype is real (appetite suppression, weight loss) but so are the nuances: side effects, cost, and the question of what to do once someone has already reached their target. In clinic, I adjust GLP-1 dosing almost every day, not by mechanically stepping up per the label, but by making evidence-based tweaks to match weight, body fat, muscle

In clinic, whenever coffee comes up, many people tense up. The same questions appear again and again: “Is it safe to drink coffee if I have a heart problem?” “If I don’t drink coffee I feel exhausted—should I force myself to quit?” It doesn’t help that media headlines often contradict one another. One day coffee is praised for lowering cancer risk and extending life; the next it’s labelled a trigger for high blood pressure and heart rhythm problems. No wonder so many people f